Literature DB >> 1758886

Review on crystal polymorphism of substances in the European pharmacopoeia.

L Borka1.   

Abstract

Substances in the European Pharmacopoeia, reported as having polymorphism are reviewed. For these substances the analyst may expect irregular melting behaviour and IR spectra.

Mesh：

Year:  1991        PMID： 1758886

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN： 0031-6865


  4 in total

1.  Solvated crystalline forms of nevirapine: thermoanalytical and spectroscopic studies.

Authors:  Renu Chadha; Poonam Arora; Anupam Saini; Dharamvir Singh Jain
Journal:  AAPS PharmSciTech       Date:  2010-08-25       Impact factor: 3.246

2.  Supercritical fluids crystallization of budesonide and flunisolide.

Authors:  Sitaram P Velaga; Rolf Berger; Johan Carlfors
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.

Authors:  F Hirayama; Z Wang; K Uekama
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

Review 4.  Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs.

Authors:  Roberta Censi; Piera Di Martino
Journal:  Molecules       Date:  2015-10-15       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.